《大行報告》摩通下調ASMPT(00522.HK)目標價至70元 評級「中性」
摩根大通發表研究報告,ASMPT(00522.HK)今年第二季經營溢利符合預期,但由於訂單疲軟趨勢,第三季收入指引差過預期,下調2022和2023年業績預測,以反映收入趨勢疲軟,維持評級「中性」,目標價由83元下調至70元,在外包半導體設備組裝與測試(OSAT)資本支出下降週期中,預計股價短期保持區間波動。
摩通指,先進封裝佔ASMPT上半年收入的約18%,並將仍然是關鍵長期增長動力,但近期增長可能顛簸,不過其股價對差過預期的指引的最初反應是好於預期,因為市場似乎已經預料到了一些負面的表述,這表明觸底反彈的過程可能已經開始。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.